Prevalence of Anti-PF4 Antibodies After First and Second ChAdOx1 nCoV-19 Vaccinations in Women With Adverse Events: A Brief Report and Literature Review
Ann Lab Med
.
2023 May 1;43(3):299-302.
doi: 10.3343/alm.2023.43.3.299.
Epub 2022 Dec 22.
Authors
Kye Won Choe
1
,
Yong Kwan Lim
1
,
Oh Joo Kweon
1
,
Mi-Kyung Lee
1
,
Jin-Won Chung
2
,
Hye Ryoun Kim
1
Affiliations
1
Department of Laboratory Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
2
Department of Internal Medicine, Division of Infectious Diseases, Chung-Ang University College of Medicine, Seoul, Korea.
PMID:
36544343
PMCID:
PMC9791014
DOI:
10.3343/alm.2023.43.3.299
No abstract available
Publication types
Review
Letter
MeSH terms
Antibodies, Viral
ChAdOx1 nCoV-19*
Female
Humans
Prevalence
Vaccination* / adverse effects
Substances
ChAdOx1 nCoV-19
Antibodies, Viral